Cargando…
Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation‐associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report
Maternally inherited diabetes and deafness is a rare genetic disease mainly caused by a point mutation in mitochondrial deoxyribonucleic acid. Lipoprotein lipase gene mutations are associated with familial dyslipidemias, which are difficult to manage. We reported for the first time a case that had b...
Autores principales: | Zhang, Xiaojuan, Chen, Yongyong, Tong, Nanwei, Shao, Qing, Zhou, Yueyang, Mu, Tong, Yang, Xiaoling, Zhang, Yuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847153/ https://www.ncbi.nlm.nih.gov/pubmed/34460997 http://dx.doi.org/10.1111/jdi.13651 |
Ejemplares similares
-
Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017) -
Neonatal hyperlipidemia with pancreatitis: Novel gene mutation of lipoprotein lipase
por: Shah, MH, et al.
Publicado: (2018) -
Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome
por: Chan, Dick C., et al.
Publicado: (2009) -
A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments
por: Li, Xiao-Hua, et al.
Publicado: (2023) -
The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion
por: Wung, Shu-Fen, et al.
Publicado: (2006)